Literature DB >> 31658964

New Antifungal Susceptibility Test Based on Chitin Detection by Image Cytometry.

Yan Wang1, Arisandy N Andriampamonjy1, Sebastien Bailly2, Cécile Garnaud1, Danièle Maubon1, Muriel Cornet1, Delphine Aldebert3.   

Abstract

The antifungal susceptibility tests used in clinical laboratories have several limitations. We developed a new test, SensiFONG, based on the detection of chitin levels after exposure to antifungal drugs. The optimal culture conditions were 30°C for 6 h for yeast strains and 26°C for 16 h for molds. The strains were exposed to a range of echinocandin or azole concentrations. Chitin was stained with calcofluor white. The percentage of fungal cells with high chitin levels was determined with an automatic epifluorescence microscope. The SensiFONG results were compared to those with the EUCAST method. Image acquisition and analysis were performed with ScanR software. Fifty-nine strains (28 Candida albicans, 17 Candida glabrata, and 14 Aspergillus fumigatus) were analyzed. Thresholds for the classification of strains as resistant or susceptible were determined for each fungal species. The strains displaying an increase in chitin content of ≥32% for C. albicans, ≥6% for C. glabrata, and ≥17% for A. fumigatus were considered susceptible. The application of these thresholds to all 59 strains resulted in a sensitivity of 0.87, 0.93, and 1.00 and a specificity of 0.93, 0.84, and 0.82 for C. albicans, C. glabrata, and A. fumigatus, respectively. The correlation between the results obtained in the SensiFONG and EUCAST assays was excellent. We developed a new test, SensiFONG, based on a new concept. While current assays assess growth inhibition, our test detects changes in chitin levels after exposure to antifungal drugs. Here, we present preliminary results and we propose a proof of concept of this methodology.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Aspergilluszzm321990; Candidazzm321990; antifungal susceptibility test; chitin; image cytometry

Year:  2019        PMID: 31658964      PMCID: PMC7187566          DOI: 10.1128/AAC.01101-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

Review 2.  The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.

Authors:  Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

Review 3.  Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

Authors:  Danièle Maubon; Cécile Garnaud; Thierry Calandra; Dominique Sanglard; Muriel Cornet
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

4.  Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.

Authors:  Susann Rößler; Oliver Bader; Friedrich Stölzel; Ulrich Sommer; Birgit Spiess; Stephan Geibel; Dieter Buchheidt; Uwe Groß; Gustavo Baretton; Enno Jacobs; Luis Ostrosky-Zeichner
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 5.  Invasive Fungal Infections in the Intensive Care Unit.

Authors:  Luis Ostrosky-Zeichner; Mohanad Al-Obaidi
Journal:  Infect Dis Clin North Am       Date:  2017-07-05       Impact factor: 5.982

6.  Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.

Authors:  Cécile Garnaud; Françoise Botterel; Natacha Sertour; Marie-Elisabeth Bougnoux; Eric Dannaoui; Sylvie Larrat; Christophe Hennequin; Jesus Guinea; Muriel Cornet; Danièle Maubon
Journal:  J Antimicrob Chemother       Date:  2015-05-27       Impact factor: 5.790

7.  Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

Authors:  Barbara D Alexander; Melissa D Johnson; Christopher D Pfeiffer; Cristina Jiménez-Ortigosa; Jelena Catania; Rachel Booker; Mariana Castanheira; Shawn A Messer; David S Perlin; Michael A Pfaller
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

8.  Home Environment as a Source of Life-Threatening Azole-Resistant Aspergillus fumigatus in Immunocompromised Patients.

Authors:  Rose-Anne Lavergne; Taieb Chouaki; Ferry Hagen; Bénédicte Toublanc; Hervé Dupont; Vincent Jounieaux; Jacques F Meis; Florent Morio; Patrice Le Pape
Journal:  Clin Infect Dis       Date:  2016-09-28       Impact factor: 9.079

9.  Fungal echinocandin resistance.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Fungal Genet Biol       Date:  2009-09-19       Impact factor: 3.495

10.  The Stress-Activated Signaling (SAS) Pathways of a Human Fungal Pathogen, Cryptococcus neoformans.

Authors:  Kwang-Woo Jung; Yong-Sun Bahn
Journal:  Mycobiology       Date:  2009-09-30       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.